NEW YORK (GenomeWeb News) – The Translational Genomics Research Institute and its partners Nemucore Medical Innovations and Barrow Neurological Institute at St. Joseph's Hospital and Medical Center have received a $3 million grant to fund a personalized glioblastoma treatment study.

TGen said yesterday that the funding from the Ben & Catherine Ivy Foundation will support a trial using individual tumor genetics to optimize targeted glioblastoma therapies that will be delivered via nanotechnology tools.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.